Chaparral Business Center Welcomes Nextiva and Regenesis Biomedical

SALT RIVER PIMA-MARICOPA INDIAN COMMUNITY, Ariz., May 16, 2012 /PRNewswire/ -- Salt River Devco is pleased to announce two major tenants for Chaparral Business Center.  Nextiva, Inc. leased 25,883 square feet at Chaparral Business Center II and Regenesis Biomedical, Inc. leased 26,455 square feet at Chaparral Business Center V. "We're excited to have these growing companies in the project and look forward to being their Real Estate partner for many years to come," said Jeff Roberts, Asset Manager.

"As leaders in web based research and biotechnology, both Nextiva and Regenesis Biomedical are outstanding complements to our tenant mix," added Vince Lujan, CEO Salt River Devco.

"Our rapid business growth and expanding presence in the community necessitated that we relocate our corporate headquarters to a facility that can accommodate our specific requirements now and hereafter," said Dennis Genge, CFO and Vice President of Finance of Regenesis.  "This location provides the facilities, flexibility and central location we need."

Salt River Devco, an enterprise of the Salt River Pima-Maricopa Indian Community, is an asset management and commercial development company.  It manages 108 acres of land and six commercial buildings comprised of 370,000 square feet at the Chaparral Business Center.  The Center is a Class A office park, located along the 101 Corridor between Chaparral and McDonald Drive on the Salt River Pima-Maricopa Indian Community.  Up to 1 million square feet of office, industrial, retail and medical uses is master planned.  Contact Jeff Roberts, 480-850-5701; www.saltriverdevco.com

Privately held member of the United Web family

Nextiva is a privately held member of the United Web family and a leading provider of cloud-based, VoIP (Voice over Internet Protocol) business communication services. Nextiva delivers "Fortune 500" phone service at start-up prices and serves thousands of small-to-midsize companies across the United States.  www.nextiva.com

Regenesis Biomedical, Inc. is a privately held medical research company developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and markets the Provant® Therapy System.  www.regenesisbio.com.